Filed: 5/14/2025ACC: 0000935836-25-000328
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 66 equity positions with a total reported market value of $102.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
66
Positions
$102.76M
Total AUM (reported)
20.28M
Total Shares
Allocation by class
COM$67.00M65.2%
COM NEW$29.16M28.4%
ORD$2.90M2.8%
SPON ADR$2.36M2.3%
COM SHS$844.9K0.8%
SPONSORED ADS$398.5K0.4%
SPONS ADR NEW$105.0K0.1%
Portfolio Concentration
Top 3$34.53M33.6%
4–10$25.15M24.5%
11–25$29.40M28.6%
Rest$13.68M13.3%
Top 3 weight
33.6%
Top 10 weight
58.1%
Voting Authority Distribution
Total shares with voting rights: 21.64M
Sole
Full voting authority
21.64M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole66
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings66
Rows:
ANI PHARMACEUTICALS INC
SOLEShares48K
TypeSH
Market value$13.65M
13.28%
Sole
48K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares1.13M
TypeSH
Market value$13.65M
13.28%
Sole
1.13M
Shared
0.00
None
0.00
OPTINOSE INC
SOLEShares788.65K
TypeSH
Market value$7.23M
7.04%
Sole
788.65K
Shared
0.00
None
0.00
ZEVRA THERAPEUTICS INC
SOLEShares650K
TypeSH
Market value$4.87M
4.74%
Sole
650K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares613K
TypeSH
Market value$3.70M
3.60%
Sole
613K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares333.40K
TypeSH
Market value$3.69M
3.59%
Sole
333.40K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares285.78K
TypeSH
Market value$3.33M
3.24%
Sole
285.78K
Shared
0.00
None
0.00
ANIKA THERAPEUTICS INC
SOLEShares206.64K
TypeSH
Market value$3.26M
3.17%
Sole
206.64K
Shared
0.00
None
0.00
ENANTA PHARMACEUTICALS INC
SOLEShares590.74K
TypeSH
Market value$3.26M
3.17%
Sole
590.74K
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$3.04M
2.96%
Sole
200K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares74.50K
TypeSH
Market value$3.04M
2.96%
Sole
74.50K
Shared
0.00
None
0.00
INDIVIOR PLC
SOLEShares304K
TypeSH
Market value$2.90M
2.82%
Sole
304K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares348.82K
TypeSH
Market value$2.77M
2.69%
Sole
348.82K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares527.84K
TypeSH
Market value$2.77M
2.69%
Sole
527.84K
Shared
0.00
None
0.00
XOMA ROYALTY CORPORATION
SOLEShares129.81K
TypeSH
Market value$2.59M
2.52%
Sole
129.81K
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares2.06M
TypeSH
Market value$2.51M
2.44%
Sole
2.06M
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares93.97K
TypeSH
Market value$2.36M
2.30%
Sole
93.97K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares914.97K
TypeSH
Market value$2.00M
1.95%
Sole
914.97K
Shared
0.00
None
0.00
HERON THERAPEUTICS INC
SOLEShares796.10K
TypeSH
Market value$1.75M
1.70%
Sole
796.10K
Shared
0.00
None
0.00
EDESA BIOTECH INC
SOLEShares687.50K
TypeSH
Market value$1.68M
1.63%
Sole
1.68M
Shared
0.00
None
0.00
MYOMO INC
SOLEShares276.71K
TypeSH
Market value$1.33M
1.30%
Sole
276.71K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$1.02M
0.99%
Sole
100K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares144.63K
TypeSH
Market value$937.2K
0.91%
Sole
144.63K
Shared
0.00
None
0.00
SCPHARMACEUTICALS INC
SOLEShares347.69K
TypeSH
Market value$914.4K
0.89%
Sole
347.69K
Shared
0.00
None
0.00
INOVIO PHARMACEUTICALS INC
SOLEShares518.33K
TypeSH
Market value$844.9K
0.82%
Sole
518.33K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ANI PHARMACEUTICALS INCSOLE | COM | 48K | SH | $13.65M 13.28% | 48K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 1.13M | SH | $13.65M 13.28% | 1.13M | 0.00 | 0.00 |
OPTINOSE INCSOLE | COM NEW | 788.65K | SH | $7.23M 7.04% | 788.65K | 0.00 | 0.00 |
ZEVRA THERAPEUTICS INCSOLE | COM NEW | 650K | SH | $4.87M 4.74% | 650K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 613K | SH | $3.70M 3.60% | 613K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 333.40K | SH | $3.69M 3.59% | 333.40K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 285.78K | SH | $3.33M 3.24% | 285.78K | 0.00 | 0.00 |
ANIKA THERAPEUTICS INCSOLE | COM | 206.64K | SH | $3.26M 3.17% | 206.64K | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS INCSOLE | COM | 590.74K | SH | $3.26M 3.17% | 590.74K | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCSOLE | COM | 200K | SH | $3.04M 2.96% | 200K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 74.50K | SH | $3.04M 2.96% | 74.50K | 0.00 | 0.00 |
INDIVIOR PLCSOLE | ORD | 304K | SH | $2.90M 2.82% | 304K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 348.82K | SH | $2.77M 2.69% | 348.82K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 527.84K | SH | $2.77M 2.69% | 527.84K | 0.00 | 0.00 |
XOMA ROYALTY CORPORATIONSOLE | COM NEW | 129.81K | SH | $2.59M 2.52% | 129.81K | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 2.06M | SH | $2.51M 2.44% | 2.06M | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 93.97K | SH | $2.36M 2.30% | 93.97K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 914.97K | SH | $2.00M 1.95% | 914.97K | 0.00 | 0.00 |
HERON THERAPEUTICS INCSOLE | COM | 796.10K | SH | $1.75M 1.70% | 796.10K | 0.00 | 0.00 |
EDESA BIOTECH INCSOLE | COM NEW | 687.50K | SH | $1.68M 1.63% | 1.68M | 0.00 | 0.00 |
MYOMO INCSOLE | COM NEW | 276.71K | SH | $1.33M 1.30% | 276.71K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 100K | SH | $1.02M 0.99% | 100K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 144.63K | SH | $937.2K 0.91% | 144.63K | 0.00 | 0.00 |
SCPHARMACEUTICALS INCSOLE | COM | 347.69K | SH | $914.4K 0.89% | 347.69K | 0.00 | 0.00 |
INOVIO PHARMACEUTICALS INCSOLE | COM SHS | 518.33K | SH | $844.9K 0.82% | 518.33K | 0.00 | 0.00 |
Page 1 of 3